AIM ImmunoTech Inc.

AIM | AMEX

Price Alert Chart Builder DCF Calculator

$0.39

$0.00 (0.00%)

Nov 2, 2026, 10:15 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $1.33M

Enterprise Value $22.38K

Beta 1.24

Average Volume 27.36M

Shares Outstanding (Diluted) 4.35M

Shares Change YoY 124.42%

Institutional Ownership 0.00%

Exchange AMEX

ISIN US00901B3033

Price Performance

Price Change 1M 14.7%

Price Change 3M -42.3%

Price Change 6M -73.1%

Price Change YTD -67.2%

Price Change 1Y -94.1%

Price Change 3Y -99.1%

Price Change 5Y -99.8%

1M CAGR (ann.) 0.3%

1Y CAGR (ann.) -92.1%

5Y CAGR (ann.) -69.4%

All-Time CAGR -45.8%

Valuation

PE Ratio -0.21

Forward PE N/A

PEG Ratio -0.00

Forward PEG N/A

PS Ratio 14.12

Forward PS 13.30

PB Ratio 0.62

P/FCF Ratio -0.11

P/Adj. FCF Ratio -0.11

P/OCF Ratio -0.15

EV/Sales 0.24

EV/EBIT -0.00

EV/EBITDA -0.00

EV/FCF -0.00

Earnings Yield -466.7%

FCF Yield -872.2%

Adj. FCF Yield -872.2%

Financial Health

Net Cash $1.41M

Total Debt $4.57M

Cash & Short-Term Investments $5.88M

Total Assets $8.59M

Current Ratio 1.01

Quick Ratio 1.01

Debt / Equity Ratio 2.15

Debt / EBITDA -0.39

Debt / FCF -0.40

OCF / Debt -2.47

Interest Coverage -10.27

Altman Z-Score -76.72

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin -133.0%

Operating Profit Margin -10839.4%

EBITDA Margin -12336.2%

Net Profit Margin -14123.4%

FCF Margin -12316.0%

Adj. FCF Margin -12316.0%

SBC / Revenue 0.0%

SBC Impact (per share) N/A

Returns

Return on Assets -154.6%

Return on Equity 261.8%

Return on Invested Capital -152.1%

Return on Capital Employed -417.6%

Return on Tangible Assets -191.8%

Historical Growth (CAGR)

Revenue CAGR 3Y -14.5%

Revenue CAGR 5Y -11.6%

Revenue CAGR 10Y -4.0%

EPS CAGR 3Y 13.8%

EPS CAGR 5Y 9.5%

EPS CAGR 10Y 9.9%

FCF CAGR 3Y 11.0%

FCF CAGR 5Y 0.0%

FCF CAGR 10Y 3.4%

Analyst Forecasts

Analyst Rating N/A

Analyst Count N/A

EPS Growth Next 3Y 22.3%

Revenue Growth Next 3Y -7.5%

Earnings Date Aug 13, 2026

EPS Estimate (next Q) -$0.17

EPS Growth Est (next Q) -95.4%

Revenue Est (next Q) $100K

Revenue Growth Est (next Q) 300.0%

Cash Flow

Operating Cash Flow $-11.32M

Free Cash Flow $-11.58M

Adj. Free Cash Flow $-11.58M

FCF Per Share -$2.66

OCF Per Share -$2.60

OCF/S Ratio -12037.2%

Income Statement

Revenue $94K

Gross Profit $-125K

Operating Income $-10.19M

EBITDA $-11.6M

Net Income $-13.28M

EPS (Diluted) -$1.82

Revenue / Employee $4.48K

Profit / Employee $-632.19K

Employees 21